19:02:48 EDT Sat 21 May 2022
Enter Symbol
or Name

Login ID:

Cannabis Summary for May 12, 2022

2022-05-12 20:09 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index added 2.62 to 54.52, while the CSE Composite Index lost 1.47 to 316.51. South of the border, Kim Rivers's U.S. MSO (multistate operator), Trulieve Cannabis Corp. (TRUL), added 61 cents to $18.27 on 779,400 shares. Investors finally reacted with something other than despair to an MSO's first quarter financials -- even if the gain has something of the appearance of a correction, given that the stock had already fallen from nearly $20 over the past two weeks.

The financials did stand out relative to other MSOs. Notably, Trulieve's revenue of $318.3-million (U.S.) in the first quarter was an increase from $305.3-million (U.S.) in the fourth quarter, no small feat. Analysts were predicting flat revenue of $305-million (U.S.). Adjusted EBITDA of $105-million (U.S.) also came in ahead of analysts' predictions of $99.6-million (U.S.). Chief executive officer Ms. Rivers reiterated Trulieve's full-year guidance of $1.3-billion (U.S.) to $1.4-billion (U.S.) in revenue and $450-million (U.S.) to $500-million (U.S.) in adjusted EBITDA.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2022 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.